# Broadstone Net Lease, Inc.: financial statements, quarterly

BNL · NYSE · CIK 1424182 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bnl.md) · [Financials](/companies/bnl/financials.md) · [Filings](/companies/bnl/filings.md) · [Insiders](/companies/bnl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bnl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [110](/filings/0000950170-24-119514.md) | [105 d](/filings/0001424182-26-000012.md) | [105](/filings/0000950170-25-061814.md) | [106](/filings/0001424182-25-000021.md) | [108](/filings/0001424182-25-000037.md) | [112 d](/filings/0001424182-26-000012.md) | [109](/filings/0001424182-26-000037.md) | [113](/filings/0001424182-26-000068.md) | [114](/filings/0001424182-25-000037.md) | [118 d](/filings/0001424182-26-000012.md) | [121](/filings/0001424182-26-000037.md) | [122](/filings/0001424182-26-000068.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [19.7](/filings/0000950170-24-119514.md) | [19.0 d](/filings/0000950170-25-024123.md) | [18.6](/filings/0000950170-25-061814.md) | [17.8](/filings/0000950170-24-088527.md) | [18.2](/filings/0000950170-24-119514.md) | [19.6 d](/filings/0000950170-25-024123.md) | [20.1](/filings/0000950170-25-061814.md) | [21.1](/filings/0001424182-26-000068.md) | [28.2](/filings/0001424182-25-000037.md) | [25.1 d](/filings/0001424182-26-000012.md) | [25.3](/filings/0001424182-26-000037.md) | [25.8](/filings/0001424182-26-000068.md) |
| Income tax | $m | not reported | not reported | not reported | [0.5](/filings/0001424182-25-000021.md) | [(0.3)](/filings/0001424182-25-000037.md) | [0.5 d](/filings/0001424182-26-000012.md) | [0.4](/filings/0001424182-26-000037.md) | [0.2](/filings/0001424182-26-000068.md) | [0.2](/filings/0001424182-25-000037.md) | [0.4 d](/filings/0001424182-26-000012.md) | [0.3](/filings/0001424182-26-000037.md) | [0.3](/filings/0001424182-26-000068.md) |
| Net income | $m | [49.7](/filings/0000950170-24-119514.md) | [6.5 d](/filings/0001424182-26-000012.md) | [65.1](/filings/0000950170-25-061814.md) | [35.3](/filings/0001424182-25-000021.md) | [35.6](/filings/0001424182-25-000037.md) | [26.4 d](/filings/0001424182-26-000012.md) | [16.7](/filings/0001424182-26-000037.md) | [20.2](/filings/0001424182-26-000068.md) | [26.5](/filings/0001424182-25-000037.md) | [33.1 d](/filings/0001424182-26-000012.md) | [46.4](/filings/0001424182-26-000037.md) | [39.8](/filings/0001424182-26-000068.md) |
| Diluted EPS | $ per share | [0.26](/filings/0000950170-24-119514.md) | not reported | [0.35](/filings/0000950170-25-061814.md) | [0.19](/filings/0001424182-25-000021.md) | [0.19](/filings/0001424182-25-000037.md) | not reported | [0.09](/filings/0001424182-26-000037.md) | [0.10](/filings/0001424182-26-000068.md) | [0.14](/filings/0001424182-25-000037.md) | not reported | [0.24](/filings/0001424182-26-000037.md) | [0.21](/filings/0001424182-26-000068.md) |
| Basic EPS | $ per share | [0.27](/filings/0000950170-24-119514.md) | not reported | [0.35](/filings/0000950170-25-061814.md) | [0.19](/filings/0001424182-25-000021.md) | [0.19](/filings/0001424182-25-000037.md) | not reported | [0.09](/filings/0001424182-26-000037.md) | [0.11](/filings/0001424182-26-000068.md) | [0.14](/filings/0001424182-25-000037.md) | not reported | [0.24](/filings/0001424182-26-000037.md) | [0.21](/filings/0001424182-26-000068.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [35.1](/filings/0000950170-24-119514.md) | [19.5](/filings/0001424182-26-000012.md) | [222](/filings/0000950170-25-061814.md) | [18.3](/filings/0001424182-25-000021.md) | [9.0](/filings/0001424182-25-000037.md) | [14.8](/filings/0001424182-26-000068.md) | [9.6](/filings/0001424182-26-000037.md) | [20.8](/filings/0001424182-26-000068.md) | [82.0](/filings/0001424182-25-000037.md) | [30.5](/filings/0001424182-26-000068.md) | [20.3](/filings/0001424182-26-000037.md) | [11.1](/filings/0001424182-26-000068.md) |
| Total assets | $m | [5,335](/filings/0000950170-23-058155.md) | [5,269](/filings/0000950170-25-024123.md) | [5,270](/filings/0000950170-24-052047.md) | [5,265](/filings/0000950170-24-088527.md) | [5,263](/filings/0000950170-24-119514.md) | [5,216](/filings/0001424182-26-000012.md) | [5,237](/filings/0000950170-25-061814.md) | [5,327](/filings/0001424182-25-000021.md) | [5,519](/filings/0001424182-25-000037.md) | [5,717](/filings/0001424182-26-000068.md) | [5,845](/filings/0001424182-26-000037.md) | [5,865](/filings/0001424182-26-000068.md) |
| Total liabilities | $m | [2,060](/filings/0000950170-23-058155.md) | [2,074](/filings/0000950170-25-024123.md) | [2,052](/filings/0000950170-24-052047.md) | [2,067](/filings/0000950170-24-088527.md) | [2,125](/filings/0000950170-24-119514.md) | [2,075](/filings/0001424182-26-000012.md) | [2,156](/filings/0000950170-25-061814.md) | [2,291](/filings/0001424182-25-000021.md) | [2,507](/filings/0001424182-25-000037.md) | [2,684](/filings/0001424182-26-000068.md) | [2,824](/filings/0001424182-26-000037.md) | [2,857](/filings/0001424182-26-000068.md) |
| Long-term debt | $m | [1,904](/filings/0000950170-23-058155.md) | [1,920](/filings/0000950170-24-018725.md) | [1,902](/filings/0000950170-24-052047.md) | [1,907](/filings/0000950170-24-088527.md) | [1,953](/filings/0000950170-24-119514.md) | [1,920](/filings/0000950170-25-024123.md) | [2,000](/filings/0000950170-25-061814.md) | [2,124](/filings/0001424182-25-000021.md) | [2,353](/filings/0001424182-25-000037.md) | [2,523](/filings/0001424182-26-000012.md) | [2,654](/filings/0001424182-26-000037.md) | [2,688](/filings/0001424182-26-000068.md) |
| Shareholders' equity | $m | [3,121](/filings/0000950170-23-058155.md) | [3,049](/filings/0000950170-25-024123.md) | [3,074](/filings/0000950170-24-052047.md) | [3,055](/filings/0000950170-24-088527.md) | [2,999](/filings/0000950170-24-119514.md) | [3,004](/filings/0001424182-26-000012.md) | [2,950](/filings/0000950170-25-061814.md) | [2,907](/filings/0001424182-25-000021.md) | [2,885](/filings/0001424182-25-000037.md) | [2,902](/filings/0001424182-26-000068.md) | [2,892](/filings/0001424182-26-000037.md) | [2,881](/filings/0001424182-26-000068.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [73.9 d](/filings/0000950170-24-119514.md) | [60.6 d](/filings/0001424182-26-000012.md) | [70.9](/filings/0000950170-25-061814.md) | [74.2 d](/filings/0001424182-25-000021.md) | [67.3 d](/filings/0001424182-25-000037.md) | [63.9 d](/filings/0001424182-26-000012.md) | [71.5](/filings/0001424182-26-000037.md) | [79.3 d](/filings/0001424182-26-000068.md) | [64.2 d](/filings/0001424182-25-000037.md) | [84.6 d](/filings/0001424182-26-000012.md) | [76.1](/filings/0001424182-26-000037.md) | [58.2 d](/filings/0001424182-26-000068.md) |
| Capital expenditure | $m | [5.9 d](/filings/0000950170-24-119514.md) | [16.8 d](/filings/0001424182-26-000012.md) | [3.1](/filings/0000950170-25-061814.md) | [0.2 d](/filings/0001424182-25-000021.md) | [7.0 d](/filings/0001424182-25-000037.md) | [6.4 d](/filings/0001424182-26-000012.md) | [14.3](/filings/0001424182-26-000037.md) | [2.6 d](/filings/0001424182-26-000068.md) | [6.2 d](/filings/0001424182-25-000037.md) | [6.6 d](/filings/0001424182-26-000012.md) | [1.4](/filings/0001424182-26-000037.md) | [11.8 d](/filings/0001424182-26-000068.md) |
| Dividends paid | $m | [51.5 d](/filings/0000950170-24-119514.md) | [52.5 d](/filings/0001424182-26-000012.md) | [54.4](/filings/0000950170-25-061814.md) | [53.9 d](/filings/0001424182-25-000021.md) | [53.5 d](/filings/0001424182-25-000037.md) | [54.8 d](/filings/0001424182-26-000012.md) | [56.2](/filings/0001424182-26-000037.md) | [55.2 d](/filings/0001424182-26-000068.md) | [52.5 d](/filings/0001424182-25-000037.md) | [54.9 d](/filings/0001424182-26-000012.md) | [55.7](/filings/0001424182-26-000037.md) | [56.1 d](/filings/0001424182-26-000068.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [183](/filings/0000950170-23-058155.md) | [196](/filings/0000950170-24-052047.md) | [196](/filings/0000950170-24-088527.md) | [196](/filings/0000950170-24-119514.md) | [196](/filings/0000950170-25-061814.md) | [196](/filings/0001424182-25-000021.md) | [197](/filings/0001424182-25-000037.md) | [197](/filings/0001424182-26-000037.md) | [197](/filings/0001424182-26-000068.md) | [198](/filings/0001424182-25-000037.md) | [200](/filings/0001424182-26-000037.md) | [200](/filings/0001424182-26-000068.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 191,892,971 at 2026-07-24, from the cover of the [10-Q/A filed 2026-07-29](/filings/0001424182-26-000068.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.